Abstract
Magnesium is a cation found primarily in a bound state and serves as a critical cofactor for ATP-dependent reactions. It is important in physiological processes such as energy release, enzymatic activation, muscle contractility, and synaptic transmission. The homeostasis of magnesium depends on the balance of a variety of factors such as parathyroid hormone, calcitonin, insulin, glucose, ADH, glucagon, catecholamines, and other electrolytes (calcium, sodium, potassium, and phosphorous). Magnesium metabolic disturbances are commonly present in critically ill patients admitted to ICU. Hypermagnesemia and hypomagnesemia may be associated with the development of life-threatening complications and organ dysfunction among ICU cancer patients. They lead to higher morbidity and mortality due to associated conditions as hypokalemia, hypocalcemia, cardiac arrhythmias, neurotoxicity, and psychiatric impairments. Because critically ill patients with cancer are predisposed to both symptomatic and asymptomatic hypermagnesemia and hypomagnesemia, ICU clinicians should avoid and manage them because of their impact on survival and length of ICU.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alsirafy SA, Sroor MY, Al-Shahri MZ. Predictive impact of electrolyte abnormalities on the admission outcome and survival of palliative care cancer referrals. J Palliat Med. 2009;12(2):177–80. Available at http://www.liebertonline.com/doi/abs/10.1089/jpm.2008.0200
Bashir H, et al. Cisplatin-induced hypomagnesemia and cardiac dysrhythmia. Pediatr Blood Cancer. 2007;49(6):867–9. Available at http://doi.wiley.com/10.1002/pbc.20804
Broman M, Hansson F, Klarin B. Analysis of hypo- and hypermagnesemia in an intensive care unit cohort. Acta Anaesthesiol Scand. 2018;62(5):648–57. Available at http://www.ncbi.nlm.nih.gov/pubmed/29341068
Cholst IN, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med. 1984;310(19):1221–5. Available at http://www.nejm.org/doi/abs/10.1056/NEJM198405103101904
Coburn JW, et al. The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med. 1969;124(3):302. Available at http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.1969.00300190042007
Cohen L, Kitzes R. Pheochromocytoma – a rare cause of hypermagnesemia. Magnesium. 1985;4(2–3): 165–7. Available at http://www.ncbi.nlm.nih.gov/pubmed/4046644
Deheinzelin D, et al. Hypomagnesemia in critically ill cancer patients: a prospective study of predictive factors. Braz J Med Biol Res. 2000;33(12):1443–8. Available at http://www.ncbi.nlm.nih.gov/pubmed/11105096
Enokida T, et al. Incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with cetuximab. Front Oncol. 2016;6:196. Available at http://www.ncbi.nlm.nih.gov/pubmed/27683640
Escuela MP, et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Med. 2005; 31:151–6.
Esen F, Telci L. Magnesium in the ICU: sine qua non. Berlin/Heidelberg: Springer; 2008. p. 491–501.
Fairley J, et al. Magnesium status and magnesium therapy in critically ill patients: a systematic review. J Crit Care. 2015;30(6):1349–58.
Fakih MG, Wilding G, Lombardo J. Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Clin Colorectal Cancer. 2006;6(2):152–6.
Felsenfeld AJ, Levine BS, Rodriguez M. Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Semin Dial. 2015;28(6):564–77. Available at http://www.ncbi.nlm.nih.gov/pubmed/26303319
Haider DG, et al. Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: results from a cross-sectional study. Eur J Intern Med. 2015;26(7):504–7.
Hansen B-A, Bruserud Ø. Hypomagnesemia in critically ill patients. J Intensive Care. 2018;6(1):21. https://doi.org/10.1186/s40560-018-0291-y.
Hariri A, Mount DB, Rastegar A. Disorders of calcium, phosphate, and magnesium metabolism. In: Mount DB, Sayegh MH, Singh AK, editors. Core concepts in the disorders of fluid, electrolytes and acid-base balance. Boston: Springer US; 2013. p. 103–46. https://doi.org/10.1007/978-1-4614-3770-3_4.
Kasper DL, et al. Hypercalcemia and hypocalcemia. In: Harrison’s manual of medicine. 19th ed. New York: McGraw-Hill Education; 2016.
Koch SM, Warters RD, Mehlhorn U. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care. 2002;17(3):203–5.
Latcha S. Electrolyte disorders in critically ill patients. In: Oropello JM, Pastores SM, Kvetan V, editors. Critical care. New York: McGraw-Hill Education; 2016.
Lee J-H, et al. Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2005;35(1):63–9.
Limaye CS, et al. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India. 2011;59: 19–22.
López-Saca JM, et al. Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care. Support Care Cancer. 2013;21(2):649–52.
Markman M, et al. Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer. J Cancer Res Clin Oncol. 1991;117(2):89–90. https://doi.org/10.1007/BF01613129.
McEvoy C, Murray PT. Electrolyte disorders in critical care. In: Hall JB, Schmidt GA, Kress JP, editors. Principles of critical care. 4th ed. New York: McGraw-Hill Education; 2015.
Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care. 2008;35(2):215–37. Available at http://www.ncbi.nlm.nih.gov/pubmed/18486714
Mordes JP, Wacker WE. Excess magnesium. Pharmacol Rev. 1977;29(4):273–300. Available at http://www.ncbi.nlm.nih.gov/pubmed/364497
Nácul FE, Vieira JM. Disorders of electrolytes. In: O’Donnell JM, Nácul FE, editors. Surgical intensive care medicine. Cham: Springer International Publishing; 2016. p. 539–51. https://doi.org/10.1007/978-3-319-19668-8_40.
Navarro JF, Mora-Fernández C. Magnesium in chronic renal failure. In: Nishizawa Y, Morii H, Durlach J, editors. New perspectives in magnesium research: nutrition and health. London: Springer London; 2007. p. 303–15.
Noronha LJ, Matuschak GM. Magnesium in critical illness: metabolism, assessment, and treatment. Intensive Care Med. 2002;28(6):667–79.
Noronha LJ, Matuschak GM. Magnesium in critical illness: metabolism, assessment, and treatment. In: Pinsky MR, et al., editors. Applied physiology in intensive care medicine 2: physiological reviews and editorials. Berlin/Heidelberg: Springer Berlin Heidelberg; 2012. p. 71–83. https://doi.org/10.1007/978-3-642-28233-1_8.
Permata Sari A, et al. Admission hypomagnesemia as a mortality predictor in medical critically ill patients. Crit Care. 2014;18(Suppl 1):P431. Available at http://ccforum.biomedcentral.com/articles/10.1186/cc13621
Petrino R, Marino R. Fluids and electrolytes. In: Tintinalli JE, et al., editors. Tintinalli’s emergency medicine: a comprehensive study guide. 8th ed. New York: McGraw-Hill Education; 2016.
Reddi AS. Disorders of calcium: hypocalcemia. In: Fluid, electrolyte and acid-base disorders. New York: Springer New York; 2014a. p. 201–13.
Reddi AS. Disorders of magnesium: hypermagnesemia. In: Fluid, electrolyte and acid-base disorders. New York: Springer New York; 2014b. p. 285–8.
Reddi AS. Disorders of magnesium: hypomagnesemia. In: Fluid, electrolyte and acid-base disorders. New York: Springer New York; 2014c. p. 271–83.
Rodríguez-Ortiz ME, et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol Dial Transplant. 2014;29(2): 282–9.
Romani AMP. Magnesium in health and disease. In: Sigel A, Sigel H, Sigel RKO, editors. Interrelations between essential metal ions and human diseases. Dordrecht: Springer Netherlands; 2013. p. 49–79. https://doi.org/10.1007/978-94-007-7500-8_3.
Rosner MH, Capasso G, Perazella MA. Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care. 2017; 23(6):475–83.
Rubeiz GJ, et al. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med. 1993;21(2):203–9. Available at http://www.ncbi.nlm.nih.gov/pubmed/8428470
Salahudeen AK, et al. Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center. Clin J Am Soc Nephrol. 2013;8(3):347–54. Available at http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.03530412
Saleem AF, Haque A. On admission hypomagnesemia in critically ill children: risk factors and outcome. Indian J Pediatr. 2009;76(12):1227–30.
Sculier C, Gaspard N. Electrolyte disturbances and critical care seizures. In: Seizures in critical care. Cham: Springer International Publishing; 2017. p. 291–310.
Singh AK. Hypermagnesemia. In: Decision making in medicine. Mosby; 2010a. p. 390–1. https://doi.org/10.1016/B978-0-323-04107-2.50137-X.
Singh AK. Hypomagnesemia. In: Decision making in medicine. Mosby; 2010b. p. 388–9. https://doi.org/10.1016/B978-0-323-04107-2.50136-8.
Soliman HM, et al. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med. 2003;31(4):1082–7. Available at http://www.ncbi.nlm.nih.gov/pubmed/12682476. Accessed 24 June 2018.
Tangvoraphonkchai K, Davenport A. Magnesium and cardiovascular disease. Adv Chronic Kidney Dis. 2018;25(3):251–60.
Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4(2): 195–206.
Topf JM, Murray P. Hypermagnesemia. In: Lang F, editor. Encyclopedia of molecular mechanisms of disease. Berlin/Heidelberg: Springer Berlin Heidelberg; 2009. p. 907–8. https://doi.org/10.1007/978-3-540-29676-8_848.
Ulm MA, et al. Hypomagnesemia is prevalent in patients undergoing gynecologic surgery by a gynecologic oncologist. Int J Gynecol Cancer. 2016;26(7): 1320–6. Available at http://www.ncbi.nlm.nih.gov/pubmed/27643653
Waldman M, Kobrin S. Chapter 8. Disorders of magnesium balance: hypomagnesemia & hypermagnesemia. In: Lerma EV, Berns JS, Nissenson AR, editors. CURRENT diagnosis & treatment: nephrology & hypertension. New York: The McGraw-Hill Companies; 2009.
Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA. 1990;263(22):3063–4. Available at http://www.ncbi.nlm.nih.gov/pubmed/2342219
Wibe E, et al. Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer. Tidsskr Nor Laegeforen. 1991;111(19):2435–7. Available at http://www.ncbi.nlm.nih.gov/pubmed/1926084
Wyskida K, et al. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr. 2012;22(1):19–26.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Quintero, A., Racedo, J., Negrete, H. (2020). Electrolytic Abnormalities Related to Magnesium in Critically Ill Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_88
Download citation
DOI: https://doi.org/10.1007/978-3-319-74588-6_88
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74587-9
Online ISBN: 978-3-319-74588-6
eBook Packages: MedicineReference Module Medicine